tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Mitchell Kapoor, 147 are a BUY (89.63%), 9 are a HOLD (5.49%), 8 are a SELL (4.88%).
Analyst Mitchell Kapoor, carries an average stock price target met ratio of 37.88% that have a potential upside of 33.11% achieved within 64 days. Previously, Mitchell Kapoor worked at HC WAINWRIGHT.
Mitchell Kapoor’s has documented 322 price targets and ratings displayed on 15 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on LEGN, Legend Biotech Corp at 08-Apr-2025.
Analyst best performing recommendations are on SRPT (SAREPTA THERAPEUTICS).
The best stock recommendation documented was for LEGN (LEGEND BIOTECH CORP) at 4/18/2023. The price target of $66 was fulfilled within 3 days with a profit of $13.76 (26.34%) receiving and performance score of 87.8.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$36
$-0.01 (-0.03%)
$36
2 years 4 months 20 days ago
(28-Nov-2022)
3/3 (100%)
$0.35 (0.98%)
267
Hold
$36
$-0.01 (-0.03%)
$35
2 years 4 months 26 days ago
(22-Nov-2022)
3/4 (75%)
$0.4 (1.12%)
145
Hold
$36
$-0.01 (-0.03%)
2 years 4 months 26 days ago
(22-Nov-2022)
1/1 (100%)
$0.4 (1.12%)
48
Hold
$36
$-0.01 (-0.03%)
$30
2 years 4 months 26 days ago
(22-Nov-2022)
2/2 (100%)
$0.4 (1.12%)
258
Hold
$36
$-0.01 (-0.03%)
$25
2 years 4 months 27 days ago
(21-Nov-2022)
2/2 (100%)
$0.41 (1.15%)
37
Which stock is Mitchell Kapoor is most bullish on?
Which stock is Mitchell Kapoor is most reserved on?
What Year was the first public recommendation made by Mitchell Kapoor?
